Kilitch Drugs (India) Dirección
Dirección controles de criterios 2/4
Actualmente no disponemos de información suficiente sobre el CEO.
Información clave
Mukund Mehta
Chief Executive Officer (CEO)
₹6.0m
Compensación total
| Porcentaje del salario del CEO | 100.0% |
| Permanencia del CEO | 32yrs |
| Participación del CEO | 7.1% |
| Permanencia media de la dirección | sin datos |
| Promedio de permanencia en la Junta Directiva | 8.1yrs |
Actualizaciones recientes de la dirección
Recent updates
Here's Why Kilitch Drugs (India) (NSE:KILITCH) Can Manage Its Debt Responsibly
Mar 05
Kilitch Drugs (India) Limited (NSE:KILITCH) Looks Just Right With A 26% Price Jump
Feb 02We Ran A Stock Scan For Earnings Growth And Kilitch Drugs (India) (NSE:KILITCH) Passed With Ease
Jan 30Investors Shouldn't Be Too Comfortable With Kilitch Drugs (India)'s (NSE:KILITCH) Earnings
Nov 17Shareholders Would Not Be Objecting To Kilitch Drugs (India) Limited's (NSE:KILITCH) CEO Compensation And Here's Why
Sep 23These 4 Measures Indicate That Kilitch Drugs (India) (NSE:KILITCH) Is Using Debt Reasonably Well
Sep 08Here's Why Kilitch Drugs (India) (NSE:KILITCH) Has Caught The Eye Of Investors
May 05Kilitch Drugs (India) (NSE:KILITCH) Could Easily Take On More Debt
Jul 06Here's Why I Think Kilitch Drugs (India) (NSE:KILITCH) Might Deserve Your Attention Today
Apr 08These 4 Measures Indicate That Kilitch Drugs (India) (NSE:KILITCH) Is Using Debt Reasonably Well
Dec 17Is Kilitch Drugs (India) (NSE:KILITCH) Using Too Much Debt?
Mar 21Should Weakness in Kilitch Drugs (India) Limited's (NSE:KILITCH) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?
Feb 13Is Kilitch Drugs (India) (NSE:KILITCH) Weighed On By Its Debt Load?
Dec 03
Does Kilitch Drugs (India) Limited (NSE:KILITCH) Have A Place In Your Dividend Stock Portfolio?
Aug 20Should Weakness in Kilitch Drugs (India) Limited's (NSE:KILITCH) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?
Jul 16Análisis de compensación del CEO
| Fecha | Compensación total | Salario | Ingresos de la empresa |
|---|---|---|---|
| Dec 31 2023 | n/a | n/a | ₹146m |
| Sep 30 2023 | n/a | n/a | ₹140m |
| Jun 30 2023 | n/a | n/a | ₹117m |
| Mar 31 2023 | ₹6m | ₹6m | ₹104m |
| Dec 31 2022 | n/a | n/a | ₹98m |
| Sep 30 2022 | n/a | n/a | ₹85m |
| Jun 30 2022 | n/a | n/a | ₹83m |
| Mar 31 2022 | ₹6m | ₹6m | ₹74m |
| Dec 31 2021 | n/a | n/a | ₹52m |
| Sep 30 2021 | n/a | n/a | ₹63m |
| Jun 30 2021 | n/a | n/a | ₹62m |
| Mar 31 2021 | ₹6m | n/a | ₹37m |
| Dec 31 2020 | n/a | n/a | ₹17m |
| Sep 30 2020 | n/a | n/a | ₹4m |
| Jun 30 2020 | n/a | n/a | -₹3m |
| Mar 31 2020 | ₹6m | n/a | ₹8m |
Compensación vs. Mercado: La compensación total de Mukund($USD72.02K) está por encima de la media de empresas de tamaño similar en el mercado Indian ($USD39.36K).
Compensación vs. Ingresos: La compensación de Mukund ha sido consistente con los resultados de la empresa en el último año.
CEO
Mukund Mehta (70 yo)
32yrs
Permanencia
₹6,000,000
Compensación
Mr. Mukund Prataprai Mehta, B.Com, LL B., serves as the Chairman and Managing Director at Kilitch Drugs (India) Limited and has been its Executive Director since May 12, 1992. Mr. Mehta served as the Compl...
Miembros de la Junta
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| Executive Chairman & MD | 32yrs | ₹6.00m | 7.09% ₹ 383.3m | |
| Whole-time Director | 6.7yrs | ₹8.40m | 20.92% ₹ 1.1b | |
| Whole Time Director | 9.5yrs | ₹2.40m | sin datos | |
| Independent & Non Executive Director | 15.9yrs | ₹25.00k | sin datos | |
| Non-Executive Independent Director | 6.2yrs | ₹30.00k | sin datos | |
| Independent Non-Executive Director | 5.9yrs | ₹5.00k | sin datos |
8.1yrs
Permanencia media
64yo
Promedio de edad
Junta con experiencia: La junta directiva de KILITCH se considera experimentada (8 años de antigüedad promedio).